Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

FMN-coated Fluorescent Iron Oxide Nanoparticles For RCP-mediated Targeting And Labeling Of Metabolically Active Cancer And Endothelial Cells.

Jabadurai Jayapaul, M. Hodenius, Susanne Arns, W. Lederle, T. Lammers, P. Comba, F. Kiessling, Jessica Gaetjens
Published 2011 · Chemistry, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Riboflavin is an essential vitamin for cellular metabolism and is highly upregulated in metabolically active cells. Consequently, targeting the riboflavin carrier protein (RCP) may be a promising strategy for labeling cancer and activated endothelial cells. Therefore, Ultrasmall SuperParamagnetic Iron Oxide nanoparticles (USPIO) were adsorptively coated with the endogenous RCP ligand flavin mononucleotide (FMN), which renders them target-specific and fluorescent. The core diameter, surface morphology and surface coverage of the resulting FMN-coated USPIO (FLUSPIO) were evaluated using a variety of physico-chemical characterization techniques (TEM, DLS, MRI and fluorescence spectroscopy). The biocompatibility of FLUSPIO was confirmed using three different cell viability assays (Trypan blue staining, 7-AAD staining and TUNEL). In vitro evaluation of FLUSPIO using MRI and fluorescence microscopy demonstrated high labeling efficiency of cancer cells (PC-3, DU-145, LnCap) and activated endothelial cells (HUVEC). Competition experiments (using MRI and ICP-MS) with a 10- and 100-fold excess of free FMN confirmed RCP-specific uptake of the FLUSPIO by PC-3 cells and HUVEC. Hence, RCP-targeting via FMN may be an elegant way to render nanoparticles fluorescent and to increase the labeling efficacy of cancer and activated endothelial cells. This was shown for FLUSPIO, which due to their high T(2)-relaxivity, are favorably suited for MR cell tracking experiments and cancer detection in vivo.
This paper references
10.1006/JCIS.2001.7500
Nonpolymeric Coatings of Iron Oxide Colloids for Biological Use as Magnetic Resonance Imaging Contrast Agents.
D. Portet (2001)
10.1088/0957-4484/19/33/335601
Synthesis and characterization of ultra-small superparamagnetic iron oxide nanoparticles thinly coated with silica.
A. Bumb (2008)
10.1148/radiol.2532081815
RGD-labeled USPIO inhibits adhesion and endocytotic activity of alpha v beta3-integrin-expressing glioma cells and only accumulates in the vascular tumor compartment.
F. Kiessling (2009)
10.1016/S0142-9612(01)00267-8
Surface modification of superparamagnetic magnetite nanoparticles and their intracellular uptake.
Y. Zhang (2002)
10.1007/s00330-002-1721-7
Ferucarbotran (Resovist): a new clinically approved RES-specific contrast agent for contrast-enhanced MRI of the liver: properties, clinical development, and applications
P. Reimer (2002)
10.1002/1097-0215(20010920)95:5<277::AID-IJC1047>3.0.CO;2-Y
Riboflavin carrier protein: A serum and tissue marker for breast carcinoma
A. Karande (2001)
10.1088/0957-4484/19/16/165101
Synthesis and characterization of PVP-coated large core iron oxide nanoparticles as an MRI contrast agent.
Ha-young Lee (2008)
10.1007/BF00841411
Does fluorine-18 fluorodeoxyglucose metabolic imaging of tumours benefit oncology?
C. Brock (2004)
10.1109/NANO.2005.1500833
Non-polymer coated Fe/sub 3/O/sub 4/ aqueous dispersion with NH/sub 3//sup +/-surface modification as new magnetite nanoparticles and their biomedical applications
F.Y. Cheng (2005)
10.1158/0008-5472.CAN-06-1668
Specific targeting of tumor angiogenesis by RGD-conjugated ultrasmall superparamagnetic iron oxide particles using a clinical 1.5-T magnetic resonance scanner.
Chunfu Zhang (2007)
10.1148/radiol.10090050
Breast cancers: MR imaging of folate-receptor expression with the folate-specific nanoparticle P1133.
Reinhard Meier (2010)
10.1021/NL0502569
Optical and MRI multifunctional nanoprobe for targeting gliomas.
O. Veiseh (2005)
Evaluating SPIO-labelled cell MR efficiency by three-dimensional quantitative T2* MRI. NMR Biomed 2007;20:21e7
P Mowat (2007)
10.1002/anie.200902893
ZrO(HPO(4))(1-x)(FMN)(x): quick and easy synthesis of a nanoscale luminescent biomarker.
M. Roming (2010)
10.1002/smll.200700847
Linking proteins with anionic nanoparticles via protamine: ultrasmall protein-coupled probes for magnetic resonance imaging of apoptosis.
E. Schellenberger (2008)
10.1016/j.biomaterials.2010.08.078
The biological properties of iron oxide core high-density lipoprotein in experimental atherosclerosis.
T. Skajaa (2011)
10.1002/CHIN.200946278
Pushing the Sensitivity Envelope of Lanthanide-Based Magnetic Resonance Imaging (MRI) Contrast Agents for Molecular Imaging Applications
S. Aime (2009)
10.1124/jpet.105.096149
Recognition, Cointernalization, and Recycling of an Avian Riboflavin Carrier Protein in Human Placental Trophoblasts
Clifford W. Mason (2006)
10.1016/J.ADDR.2003.07.005
Current perspectives on the cellular uptake and trafficking of riboflavin.
Amy B. Foraker (2003)
10.1002/NBM.924
Iron oxide MR contrast agents for molecular and cellular imaging
J. Bulte (2004)
10.1002/smll.200900389
Drug/dye-loaded, multifunctional iron oxide nanoparticles for combined targeted cancer therapy and dual optical/magnetic resonance imaging.
Santimukul Santra (2009)
10.1002/cmmi.282
Assessing cytotoxicity of (iron oxide-based) nanoparticles: an overview of different methods exemplified with cationic magnetoliposomes.
S. Soenen (2009)
10.1002/NBM.1084
Evaluating SPIO‐labelled cell MR efficiency by three‐dimensional quantitative T  2* MRI
P. Mowat (2007)
10.2741/3477
Biochemical characterization of riboflavin carrier protein (RCP) in prostate cancer.
T. Johnson (2009)
10.1002/mrm.20617
Magnetic resonance imaging of cardiomyocyte apoptosis with a novel magneto‐optical nanoparticle
D. Sosnovik (2005)
10.1021/nl902659g
Synergistic targeting of alphavbeta3 integrin and galectin-1 with heteromultivalent paramagnetic liposomes for combined MR imaging and treatment of angiogenesis.
E. Kluza (2010)
Involvement of a receptor-mediated component in cellular translocation of riboflavin.
S. Huang (2000)
10.1016/j.biomaterials.2010.01.010
PET/NIRF/MRI triple functional iron oxide nanoparticles.
J. Xie (2010)
10.1016/j.biomaterials.2009.09.004
Iron oxide core oil-in-water emulsions as a multifunctional nanoparticle platform for tumor targeting and imaging.
P. Jarzyna (2009)
10.2174/1389201043376526
Monitoring cell therapy using iron oxide MR contrast agents.
J. Bulte (2004)
10.1021/LA061879K
Silica- and alkoxysilane-coated ultrasmall superparamagnetic iron oxide particles: a promising tool to label cells for magnetic resonance imaging.
C. Zhang (2007)
10.1161/CIRCULATIONAHA.107.719765
Noninvasive In Vivo Imaging of Monocyte Trafficking to Atherosclerotic Lesions
M. Kircher (2008)
10.1007/s00330-009-1585-1
Accelerated stem cell labeling with ferucarbotran and protamine
Daniel Golovko (2009)
RGDlabeled USPIO inhibits adhesion and endocytotic activity of alpha v beta3integrin-expressing glioma cells and only accumulates in the vascular tumor compartment. Radiology 2009;253:462e9
F Kiessling (2009)
10.1182/BLOOD-2004-06-2117
Chondrogenic differentiation of mesenchymal stem cells is inhibited after magnetic labeling with ferumoxides.
J. Bulte (2004)
10.1021/nl102623x
Coating optimization of superparamagnetic iron oxide nanoparticles for high T2 relaxivity.
S. Tong (2010)
10.1016/0026-265X(81)90135-1
Photometric determination of iron (III)
W. A. Bashir (1981)
10.1002/mrm.22011
Relaxation effects of ferucarbotran‐labeled mesenchymal stem cells at 1.5T and 3T: Discrimination of viable from lysed cells
T. Henning (2009)
10.1590/S1807-59322007000200005
Metabolic test with fluorine-18-fluorodeoxyglucose in staging and detection of residual tumor or recurrence in Hodgkin lymphoma.
L. F. Pracchia (2007)
10.1021/NL0624263
Bifunctional magnetic silica nanoparticles for highly efficient human stem cell labeling.
Chen-Wen Lu (2007)
10.3892/IJO_00000093
Clinical implication of glucose transport and metabolism evaluated by 18F-FDG PET in hepatocellular carcinoma.
B. Paudyal (2008)
Preparation and biomedical application of a non-polymer coated superparamagnetic nanoparticle
Lin Du (2007)
10.1148/RADIOL.2281020638
Clinically applicable labeling of mammalian and stem cells by combining superparamagnetic iron oxides and transfection agents.
J. Frank (2003)



This paper is referenced by
10.1016/j.biomaterials.2015.11.050
Bioengineered riboflavin in nanotechnology.
N. Beztsinna (2016)
Development and preclinical validation of molecular and nanoparticulate probes for imaging of fibrin
Lwe Luc Starmans (2014)
10.1515/bmt-2012-4472
Non-invasive Imaging of Tissue-Engineered Vascular Endothelium with Iron Oxide Nanoparticles
J. Frese (2012)
10.1515/bmt-2013-0029
Nondestructive monitoring of tissue-engineered constructs
J. Frese (2014)
10.1007/978-3-642-24133-8_8
Initial MPS Response of Adsorptively-Coated Fluorescent Iron Oxide Nanoparticles
Jabadurai Jayapaul (2012)
10.7150/thno.3462
Comparison of Two Ultrasmall Superparamagnetic Iron Oxides on Cytotoxicity and MR Imaging of Tumors
Mulan Li (2012)
10.1155/2015/593014
Cytotoxic Effects of Biosynthesized Zinc Oxide Nanoparticles on Murine Cell Lines
F. Namvar (2015)
10.1166/JBN.2015.2145
Recent Developments in Active Tumor Targeted Multifunctional Nanoparticles for Combination Chemotherapy in Cancer Treatment and Imaging.
M. Glasgow (2015)
10.25148/ETD.FI13080525
Magnetic Nanoparticle-based Targeted Drug Delivery for Treatment of Neuro-AIDS and Drug Addiction
V. Sagar (2013)
10.1007/s13738-017-1286-7
Synthesis and characterization of chitosan–polyvinylpyrrolidone–bovine serum albumin-coated magnetic iron oxide nanoparticles as potential carrier for delivery of tamoxifen
G. Prabha (2018)
10.1002/adfm.201401199
Theranostic USPIO-Loaded Microbubbles for Mediating and Monitoring Blood-Brain Barrier Permeation.
T. Lammers (2015)
10.1002/cctc.201200466
Recent Developments in Flavin‐based Catalysis
Gonzalo de Gonzalo (2013)
10.1039/C8AY00065D
Selective extraction of n-butylidenephthalide from Angelica sinensis (Danggui) by using functionalized iron oxide magnetic nanoparticles as trapping probes
Ching-yi Wu (2018)
10.1080/09205063.2014.917040
Engineered multifunctional nanomaterials for multimodal imaging of retinoblastoma cells in vitro
L. R. Jaidev (2014)
10.1039/C2JM15768C
Fluorescent-magnetic poly(poly(ethyleneglycol)monomethacrylate)-grafted Fe3O4 nanoparticles from post-atom-transfer-radical-polymerization modification: synthesis, characterization, cellular uptake and imaging
X. Lu (2012)
10.7150/thno.11304
Erythropoietin Improves the Accumulation and Therapeutic Effects of Carboplatin by Enhancing Tumor Vascularization and Perfusion
D. Doleschel (2015)
Engineered Nanoparticles for the Delivery of Anticancer
TherapeuticsBala Srinivasa Panchangam (2015)
10.1088/0957-4484/25/5/055101
Enhanced blood-brain barrier transmigration using a novel transferrin embedded fluorescent magneto-liposome nanoformulation.
H. Ding (2014)
10.1016/B978-0-444-53632-7.00407-X
4.07 – Multimodal Optical Imaging Probes
S. Fokong (2014)
10.1016/j.bioorg.2020.104213
Synthesis of new riboflavin modified ODNs: Effect of riboflavin moiety on the G-quadruplex arrangement and stability.
V. Romanucci (2020)
10.1088/2053-1591/AA9131
Synthesis of super-paramagnetic iron oxide nanoparticles assisted by brown seaweed Turbinaria decurrens for removal of reactive navy blue dye
Mohamed Mathar Sahib Ibrahim Khaleelullah (2017)
10.2147/IJN.S83150
Ultrasmall cationic superparamagnetic iron oxide nanoparticles as nontoxic and efficient MRI contrast agent and magnetic-targeting tool
Mayara K Uchiyama (2015)
10.7150/thno.3463
Targeting Strategies for Multifunctional Nanoparticles in Cancer Imaging and Therapy
M. Yu (2012)
10.1371/journal.pone.0057335
Iron Oxide Nanoparticle-Micelles (ION-Micelles) for Sensitive (Molecular) Magnetic Particle Imaging and Magnetic Resonance Imaging
L. W. Starmans (2013)
10.1016/j.phrs.2016.07.007
Nanoparticle-mediated delivery of suicide genes in cancer therapy.
R. Vago (2016)
10.1016/j.carbpol.2013.10.028
One-pot synthesis of biocompatible superparamagnetic iron oxide nanoparticles/hydrogel based on salep: characterization and drug delivery.
G. R. Bardajee (2014)
10.1177/1536012120969477
Magnetofluorescent Nanoprobe for Multimodal and Multicolor Bioimaging
Aditya Yadav (2020)
10.7150/thno.8763
FMN-Coated Fluorescent USPIO for Cell Labeling and Non-Invasive MR Imaging in Tissue Engineering
M. Mertens (2014)
10.1016/J.BIOMATERIALS.2019.119228
MR and PET-CT monitoring of tissue-engineered vascular grafts in the ovine carotid artery.
F. Wolf (2019)
10.2147/IJN.S125192
Photoacoustic imaging of tumor targeting with riboflavin-functionalized theranostic nanocarriers
N. Beztsinna (2017)
10.1002/ADFM.201504998
Novel Biological Functions of ZIF-NP as a Delivery Vehicle: High Pulmonary Accumulation, Favorable Biocompatibility, and Improved Therapeutic Outcome
Suxin Li (2016)
10.1016/j.biomaterials.2012.08.036
Riboflavin carrier protein-targeted fluorescent USPIO for the assessment of vascular metabolism in tumors.
Jabadurai Jayapaul (2012)
See more
Semantic Scholar Logo Some data provided by SemanticScholar